We are studying whether personalized coaching and education can help patients with HR+ HER2- early breast cancer stay on their ribociclib treatment. This may improve their treatment experience and overall health outcomes.
Health conditions and diseases that the clinical trial is designed to study and treat.
Hormone receptor positive breast cancer is a type of breast cancer that grows in response to hormones like estrogen. It is often treated with hormone therapy to block these hormones and reduce the risk of recurrence.
Breast cancer is a disease where malignant (cancer) cells form in the tissues of the breast. It can affect both men and women, but is much more common in women.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.